---
title: "Curaleaf Medical Cannabis with Documented Ties to Russian Capital Registered in Ukraine"
description: "Three medical cannabis extracts under the Curaleaf brand, a corporation with documented ties to Russian capital and a sanctioned bank, have been registered in Ukraine."
date: 2026-11-20T18:13:59.540Z
lang: en
url: https://xab.info/en/posts/curaleaf-medical-cannabis-ukraine-russian-ties
tags: [medical-cannabis, curaleaf, ukraine, sanctions, pharmaceuticals, roman-abramovich]
author: "Inna Kinsheva"
publisher: "XAB.info"
---

# Curaleaf Medical Cannabis with Documented Ties to Russian Capital Registered in Ukraine

![Medical cannabis in a jar with pills and a medical stethoscope on a wooden table](https://xab.info/media/2026/11/20/curaleaf-medical-cannabis-ukraine-russian-ties/curaleaf-medical-cannabis-ukraine-russian-ties-1.webp)

## Key Points

- The Ministry of Health of Ukraine registered three Curaleaf medical cannabis extracts on January 3, 2025, for the manufacture of prescription drugs.
- Curaleaf CEO Boris Jordan controls about 69% of voting power and has an extensive business career in Russia.
- Investigations document funding from Abramovich-linked structures, retention of shares by the sanctioned MCB, and Andrei Blokh's ownership of 17.6% of shares (May 2026).
- Curaleaf denies current Russian influence, citing the sale of Russian assets after going public.

On January 3, 2025, the Ministry of Health of Ukraine registered three full-spectrum medical cannabis extracts under the Curaleaf brand with varying THC and CBD ratios. The manufacturer listed in the registry is the Spanish company Medalchemy S.L., which is 97.5% indirectly owned by Curaleaf Holdings Inc., while the applicant was the Ukrainian company Pharmdistribution LLC. The registered substances are intended for the manufacture of prescription drugs in licensed pharmacies. Thus, products of an international corporation whose financing history and ownership structure, according to financial reports, state registries, and journalistic investigations, show ties to Russian business have entered the Ukrainian market.

### Who is Behind Curaleaf

Curaleaf is led by Boris Jordan, Chairman and CEO, who controls approximately 69% of shareholder voting power through multiple-voting shares. Jordan built a significant part of his career in Russia: he headed the Gazprom-Media holding and NTV television channel, worked in the oil sector, and founded the Sputnik investment group. According to a Guardian investigation, Jordan acknowledged that he previously maintained close personal relations with Vladimir Putin.

### Russian Capital in the Company's History

The involvement of Russian capital in the business began before Curaleaf went public. In 2013, PalliaTech — Curaleaf's predecessor — raised $10 million from Jordan's Sputnik Group and its Russian partners in exchange for a 35% stake. Later, according to Forensic News investigative materials, funds for acquiring PalliaTech shares and financing Jordan-linked structures were provided by Cetus Investments Limited, associated with Roman Abramovich: $14 million was documented in 2016 and $10 million in 2017. In 2018, Curaleaf received $85 million in secured debt financing from Cetus. In December 2022, Jordan confirmed to Bloomberg that Abramovich had financed Curaleaf in the early stages of its development.

### Sanctioned Bank and Shareholders

An additional episode involves the Moscow Credit Bank (MCB), which is subject to sanctions by the US, EU, UK, and Ukraine. According to an investigation by The Newsground, in 2020 the bank received 15.5 million Curaleaf shares as collateral under a deal worth approximately $77 million; following the imposition of sanctions, the stipulated buyback did not take place, and in December 2023 the bank retained the securities in its ownership — their market value at the time was around $58 million. Curaleaf stated that it had frozen the voting rights on this block of shares and restricted their transfer, sale, and dividend payouts. Major shareholders also included Andrei Blokh, former president of Sibneft and an associate of Abramovich: as of May 2026, he owned 17.6% of the corresponding class of shares, and personal sanctions by Ukraine were imposed on him in October 2022.

### Company Position

Curaleaf denies any current Russian influence on the company's operations, stating that it does not conduct business in Russia and does not receive funding from Russian oligarchs after going public. Boris Jordan has stated that he sold his Russian assets long ago and has no ties to the Russian authorities. At the same time, these statements do not negate the documented facts of Russian investors' participation in the company's establishment, financing from structures associated with Abramovich, and the transfer of shares to the sanctioned MCB. It is these circumstances that form the Russian context of the corporation whose products are now registered in Ukraine.

## Accounts differ

### Presence of Russian influence and participation in Curaleaf

- **Curaleaf / Boris Jordan:** The company does not conduct business in Russia and does not receive funding from Russian oligarchs after going public; Jordan sold Russian assets and has no ties to Russian authorities ([rbc.ua](https://www.rbc.ua/ukr/news/ispanskiy-zavod-groshi-abramovicha-ta-zv-1795177625.html))
- **RБК-Украина citing investigations by The Newsground, Forensic News, The Guardian:** MCB retained ownership of Curaleaf shares worth about $58 million, and Andrei Blokh owned 17.6% of the corresponding class of shares (May 2026) ([rbc.ua](https://www.rbc.ua/ukr/news/ispanskiy-zavod-groshi-abramovicha-ta-zv-1795177625.html))

*Where they agree:* The involvement of Abramovich-linked structures in Curaleaf's early financing was confirmed by Jordan himself in a Bloomberg interview (December 2022)

## Fact-Check & Sources

- [Деньги Абрамовича, связи с Путиным и подсанкционный банк: что не так с Curaleaf в Украине](https://www.rbc.ua/ukr/news/ispanskiy-zavod-groshi-abramovicha-ta-zv-1795177625.html) - Registration of three extracts (3.01.2025), manufacturer Medalchemy (97.5% Curaleaf), applicant Pharmdistribution LLC — according to registries and financial reporting. Financing history (Sputnik Group 2013, Cetus Investments 2016–2018) and ownership of MCB shares / Blokh — based on investigations by The Guardian, Forensic News, The Newsground. The characterization of 'current Russian influence' is disputed by Curaleaf's statement.

## FAQ

### What exactly was registered in Ukraine?

Three full-spectrum medical cannabis extracts of the Curaleaf brand with different THC and CBD ratios, registered by the Ministry of Health on January 3, 2025. The manufacturer is Spain's Medalchemy S.L. (97.5% Curaleaf), and the applicant is Pharmdistribution LLC.

### Who controls Curaleaf?

Boris Jordan, CEO and Chairman of the Board, controls about 69% of shareholder voting power through multiple-voting shares.

### What ties to Russian capital are documented?

Raising $10 million from Sputnik Group in 2013, financing through Cetus Investments (Abramovich-linked structures) in 2016–2018, retention of shares by the sanctioned MCB (about $58 million in December 2023), and Andrei Blokh's ownership of 17.6% of shares (May 2026).

### What does the company itself say?

Curaleaf denies current Russian influence, claims no business in Russia and no funding from oligarchs after going public; Jordan asserts he sold Russian assets and has no ties to Russian authorities.